Bierrenbach Ana Luiza, Choi Yoonyoung, Batista Paula de Mendonça, Serra Fernando Brandão, Parellada Cintia Irene, Julian Guilherme Silva, Nakajima Karina, Moreira Thais das Neves Fraga
Instituto de Ensino e Pesquisa, Hospital Sírio-Libanês, São Paulo 01308-050, SP, Brazil.
Merck & Co., Inc., Kenilworth, NJ 07033, USA.
Vaccines (Basel). 2021 Apr 20;9(4):407. doi: 10.3390/vaccines9040407.
In 2014, a recommended one-dose of inactivated hepatitis A vaccine was included in the Brazilian National Immunization Program targeting children 12-24 months. This decision addressed the low to intermediate endemicity status of hepatitis A across Brazil and the high rate of infection in children and adolescents between 5 and 19 years old. The aim of the study was to conduct a time-series analysis on hepatitis A incidence across age groups and to assess the hepatitis A distribution throughout Brazilian geographic regions.
An interrupted time-series analysis was performed to assess hepatitis A incidence rates before (2010-2013) and after (2015-2018) hepatitis A vaccine program implementation. The time-series analysis was stratified by age groups while a secondary analysis examined geographic distribution of hepatitis A cases.
Overall incidence of hepatitis A decreased from 3.19/100.000 in the pre-vaccine period to 0.87/100.000 ( = 0.022) post-vaccine introduction. Incidence rate reduction was higher among children aged 1-4 years old, with an annual reduction of 67.6% in the post-vaccination period against a 7.7% annual reduction in the pre-vaccination period ( < 0.001). Between 2015 and 2018, the vaccination program prevented 14,468 hepatitis A cases.
Our study highlighted the positive impact of a recommended one-dose inactivated hepatitis A vaccine for 1-4-years-old in controlling hepatitis A at national level.
2014年,巴西国家免疫规划纳入了针对12至24个月儿童的一剂次甲型肝炎灭活疫苗推荐接种方案。这一决定是鉴于巴西全国甲型肝炎的流行程度处于低至中度,以及5至19岁儿童和青少年的高感染率。本研究的目的是对各年龄组的甲型肝炎发病率进行时间序列分析,并评估巴西各地理区域甲型肝炎的分布情况。
采用中断时间序列分析,评估甲型肝炎疫苗接种方案实施前(2010 - 2013年)和实施后(2015 - 2018年)的甲型肝炎发病率。时间序列分析按年龄组分层,同时进行二次分析以检查甲型肝炎病例的地理分布。
甲型肝炎的总体发病率从疫苗接种前的3.19/10万降至疫苗接种后的0.87/10万( = 0.022)。1至4岁儿童的发病率下降幅度更大,接种疫苗后的年下降率为67.6%,而接种疫苗前的年下降率为7.7%( < 0.001)。在2015年至2018年期间,疫苗接种方案预防了14,468例甲型肝炎病例。
我们的研究强调了针对1至4岁儿童推荐的一剂次甲型肝炎灭活疫苗在国家层面控制甲型肝炎方面的积极影响。